Twist Bioscience (TWST) Total Current Liabilities (2018 - 2026)

Twist Bioscience (TWST) has reported Total Current Liabilities for 9 consecutive years, with $120.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Total Current Liabilities rose 60.02% year-over-year to $120.0 million; the TTM figure through Mar 2026 stood at $120.0 million (up 60.02% YoY), while the FY2025 annual figure was $91.4 million, up 28.73% from the prior year.
• Total Current Liabilities improved to $120.0 million in Q1 2026 per TWST's latest filing, from $80.4 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $120.0 million in Q1 2026 and bottomed at $65.2 million in Q4 2023.
• Historically, Total Current Liabilities has averaged $80.7 million across 5 years, with a median of $75.0 million in 2025.
• Annual changes were most pronounced in 2022 — Total Current Liabilities soared 109.27% — and 2023, when it decreased 22.2%.
• Twist Bioscience's Total Current Liabilities stood at $83.8 million in 2022, then retreated by 22.2% to $65.2 million in 2023, then increased by 6.77% to $69.6 million in 2024, then climbed by 15.5% to $80.4 million in 2025, then soared by 49.15% to $120.0 million in 2026.
• Business Quant data shows TWST's Total Current Liabilities at $120.0 million in Q1 2026, $80.4 million in Q4 2025, and $91.4 million in Q3 2025.